Log In
BCIQ
Print this Print this
 

Urelumab (BMS-663513)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
Description mAb agonist of tumor necrosis factor (TNF) receptor superfamily member 9 (TNFRSF9; 4-1BB, CD137)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 9 (4-1BB) (TNFRSF9) (CD137)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$12.0M

$12.0M

0


 Deals Details
Get a free BioCentury trial today